Cryo Cell International Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Cryo Cell International Inc in the second quarter 2026?
Due to the lack of equity, it was not possible to calculate Cryo Cell International Inc 's return on equity (ROE) in its second quarter 2026

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(May 31 2026) II. Quarter	(Feb 28 2026) I. Quarter	(Nov 30 2025) IV. Quarter	(Aug 31 2025) III. Quarter	(May 31 2025) II. Quarter
Y / Y Equity Change	-	-	-	-	-
Y / Y Net Income Change	55.88 %	-83.35 %	-	-28.74 %	-45.75 %
Net Income (TTM) in Millions	-2	-3	-2	0	0
Return On Equity (TTM)	-	-	-	-	-
CCEL's Total Ranking	#	#	#	#	#
Equity (TTM) in Millions	-18	-18	-19	-15	-16
Seq. Equity Change	-	-	-	-	-
Seq. Net Income Change	1077.27 %	-	-	110.64 %	25.78 %

Back to CCEL Management Effectiveness >> CCEL's 5 Years Annual ROE >> Compare CCEL ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Equity Statistics
High	Average	Low
0 %	0 %	0 %

CCEL Annual Return On Equity	(Nov 30 2025) 2025	(Nov 30 2024) 2024	(Nov 30 2023) 2023	(Nov 30 2022) 2022	(Nov 30 2021) 2021
Total Equity in Millions	-19	-13	-11	-2	4
Y / Y Equity Change	-	-	-	-	-
Net Income in Millions	-2	0	-10	3	2
Y / Y Net Income Change	-	-	-	33.02 %	-42.52 %
Return On Equity	-	-	-	-	49.79 %

Back to CCEL Management Effectiveness >> CCEL's 5 Years Annual ROE >> Compare CCEL ROE to its Competitors

Annual Roe Comment

Despite deterioration in net income, company improved ROE to in 2025, company improved ROE to 49.79 % compared to the prior year.

More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CCEL's' Return on Equity at Yahoo Finance
CCEL's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CCEL's Competitors
Subscribers only: Roe for Cryo Cell International Inc 's Suppliers
Subscribers only: Return On Equity for CCEL's Customers

Companies with similar Return On Equity at May 31 2026, within Healthcare Sector	ROE
Dexcom Inc	36.25 %
Transmedics Group Inc	33.37 %
Arcutis Biotherapeutics Inc	32.92 %
Caredx Inc	32.81 %
Zevra Therapeutics Inc	32.56 %
Acadia Pharmaceuticals Inc	32.39 %
Pro dex Inc	31.96 %
Protalix Biotherapeutics inc	31.61 %
Illumina Inc	31.08 %
Innoviva Inc	30.03 %
Phibro Animal Health Corporation	29.66 %
Chemed Corporation	29.45 %
Solventum Corporation	28.96 %
Pacs Group Inc	27.00 %
Sotera Health Company	26.75 %
Insulet Corporation	26.69 %
Bioventus Inc	25.96 %
Johnson and Johnson	25.74 %
Encompass Health Corporation	25.52 %
Resmed Inc	24.21 %
Healthcare Services Group Inc	24.12 %
Electromed Inc	23.65 %
Iradimed Corporation	23.45 %
Vertex Pharmaceuticals Inc	23.31 %
Lantheus Holdings Inc	23.27 %
Msa Safety Inc	23.15 %
Prestige Consumer Healthcare Inc	21.77 %
Jazz Pharmaceuticals Plc	21.37 %
Neurocrine Biosciences Inc	21.13 %
Universal Health Services Inc	20.89 %

Date modified: 2026-09-19T05:06:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.